180 related articles for article (PubMed ID: 29246308)
1. miR-3174 Contributes to Apoptosis and Autophagic Cell Death Defects in Gastric Cancer Cells by Targeting ARHGAP10.
Li B; Wang L; Li Z; Wang W; Zhi X; Huang X; Zhang Q; Chen Z; Zhang X; He Z; Xu J; Zhang L; Xu H; Zhang D; Xu Z
Mol Ther Nucleic Acids; 2017 Dec; 9():294-311. PubMed ID: 29246308
[TBL] [Abstract][Full Text] [Related]
2. Targeting Oncogenic miR-181a-2-3p Inhibits Growth and Suppresses Cisplatin Resistance of Gastric Cancer.
Jin L; Ma X; Zhang N; Zhang Q; Chen X; Zhang Z; Ding G; Yu H
Cancer Manag Res; 2021; 13():8599-8609. PubMed ID: 34815714
[TBL] [Abstract][Full Text] [Related]
3. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
Zhou J; Chen Q
FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis.
Eun JW; Kim HS; Shen Q; Yang HD; Kim SY; Yoon JH; Park WS; Lee JY; Nam SW
J Pathol; 2018 Jan; 244(1):107-119. PubMed ID: 28991363
[TBL] [Abstract][Full Text] [Related]
5. Gastric cancer-associated microRNA expression signatures: integrated bioinformatics analysis, validation, and clinical significance.
Liu X; Pu K; Wang Y; Chen Y; Zhou Y
Ann Transl Med; 2021 May; 9(9):797. PubMed ID: 34268410
[TBL] [Abstract][Full Text] [Related]
6. MiR-17-5p promotes cellular proliferation and invasiveness by targeting RUNX3 in gastric cancer.
Song J; Liu Y; Wang T; Li B; Zhang S
Biomed Pharmacother; 2020 Aug; 128():110246. PubMed ID: 32447210
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-let-7a regulates cell autophagy by targeting Rictor in gastric cancer cell lines MGC-803 and SGC-7901.
Fan H; Jiang M; Li B; He Y; Huang C; Luo D; Xu H; Yang L; Zhou J
Oncol Rep; 2018 Mar; 39(3):1207-1214. PubMed ID: 29328491
[TBL] [Abstract][Full Text] [Related]
8. Upregulated miR-132 in Lgr5
Zhang L; Guo X; Zhang D; Fan Y; Qin L; Dong S; Zhang L
Mol Carcinog; 2017 Sep; 56(9):2022-2034. PubMed ID: 28383763
[TBL] [Abstract][Full Text] [Related]
9. LncRNA DCST1-AS1 regulated cell proliferation, migration, invasion and apoptosis in gastric cancer by targeting miR-605-3p.
Su YZ; Cui MF; Du J; Song B
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1158-1167. PubMed ID: 32096164
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-362-5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein.
Wei X; Gao M; Ahmed Y; Gao M; Liu W; Zhang Y; Xie X; Zhao Q; Wang H; Gu K
Oncol Lett; 2019 Aug; 18(2):1607-1616. PubMed ID: 31423228
[TBL] [Abstract][Full Text] [Related]
11. LINC00963/miR-4458 regulates the effect of oxaliplatin in gastric cancer by mediating autophagic flux through targeting of ATG16L1.
Hou M; Li C; Dong S
Sci Rep; 2021 Oct; 11(1):20951. PubMed ID: 34697403
[TBL] [Abstract][Full Text] [Related]
12. Downregulated miR-383-5p contributes to the proliferation and migration of gastric cancer cells and is associated with poor prognosis.
Wei C; Gao JJ
PeerJ; 2019; 7():e7882. PubMed ID: 31637133
[TBL] [Abstract][Full Text] [Related]
13. Serum microRNAs as potential new biomarkers for cisplatin resistance in gastric cancer patients.
Jin L; Zhang N; Zhang Q; Ding G; Yang Z; Zhang Z
PeerJ; 2020; 8():e8943. PubMed ID: 32328349
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1.
Han TS; Hur K; Xu G; Choi B; Okugawa Y; Toiyama Y; Oshima H; Oshima M; Lee HJ; Kim VN; Chang AN; Goel A; Yang HK
Gut; 2015 Feb; 64(2):203-14. PubMed ID: 24870620
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation and tumor-promoting role of SPHK1 were attenuated by miR-330-3p in gastric cancer.
Wang Z; Qu H; Gong W; Liu A
IUBMB Life; 2018 Nov; 70(11):1164-1176. PubMed ID: 30281914
[TBL] [Abstract][Full Text] [Related]
16. Combining multi-dimensional data to identify a key signature (gene and miRNA) of cisplatin-resistant gastric cancer.
Zhou D; Li X; Zhao H; Sun B; Liu A; Han X; Cui Z; Yuan L
J Cell Biochem; 2018 Aug; 119(8):6997-7008. PubMed ID: 29693274
[TBL] [Abstract][Full Text] [Related]
17. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
Gu Y; Fei Z; Zhu R
Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198
[TBL] [Abstract][Full Text] [Related]
18. Retraction Notice to: miR-3174 Contributes to Apoptosis and Autophagic Cell Death Defects in Gastric Cancer Cells by Targeting ARHGAP10.
Li B; Wang L; Li Z; Wang W; Zhi X; Huang X; Zhang Q; Chen Z; Zhang X; He Z; Xu J; Zhang L; Xu H; Zhang D; Xu Z
Mol Ther Nucleic Acids; 2022 Jun; 28():591. PubMed ID: 35614989
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of microRNA-376a in Gastric Cancer and Association with Poor Prognosis.
Zhang C; Liang Y; Ma MH; Wu KZ; Zhang CD; Dai DQ
Cell Physiol Biochem; 2018; 51(5):2010-2018. PubMed ID: 30522118
[TBL] [Abstract][Full Text] [Related]
20. High expression of TCF12 contributes to gastric cancer development via being target regulated by miR-183 and activating PI3K/AKT pathway.
Wang X; Gao S; Xie F; Li W; Li M; Yan N; Gao T; Fang L
J Cell Biochem; 2019 Aug; 120(8):13903-13911. PubMed ID: 30982999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
